Dengue Haemorrhagic Fever presenting as Acute Abdomen by Al-Araimi, Hanaa et al.
Dengue virus is a mosQuito-borne flavivirus and the most prevalent arbovirus in tropical and subtropical 
regions of the world.1 The 2005 World Health 
Assembly resolution WHA58.3 on the revision of 
the International Health Regulations (IHR) has 
included dengue as an example of a disease that may 
constitute a public health emergency of international 
concern with implications for health security due 
to disruption and rapid epidemic spread beyond 
national borders.2 Acute abdomen is an uncommon 
presentation of dengue haemorrhagic fever (DHF). 
It is important to take DHF into consideration 
when making a differential diagnosis for patients 
with acute abdomen, a history of travel to dengue 
endemic areas and thrombocytopenia. Reaching the 
right diagnosis may help in preventing unnecessary 
surgical interventions for patients with DHF.
Case report
A 38 year-old Sri Lankan lady presented with a three-
day history of fever associated with abdominal pain, 
vomiting and diarrhoea. She also gave a history of 
headache. These symptoms had started on the day 
she arrived in Oman from Sri Lanka. She denied any 
history of skin rashes, urinary symptoms or contact 
with sick people. She had been working in Oman 
for the previous four years and had visited her home 
country, Sri Lanka, for four weeks coming back to 
Oman three days prior to admission to hospital. 
Clinical examination showed a sick looking and 
mildly dehydrated woman. There was no evidence 
of jaundice, lymphadenopathy or skin rash. She was 
febrile and hypotensive, but she was not tachypneic 
or tachycardic. An abdominal examination revealed 
a generalised abdominal tenderness mainly in the 
right hypochondrium, but there was no guarding 
or rigidity. Other systemic examinations were 
unremarkable. Initial investigations showed 
haemoglobin of 14.2 g/dl; haematocrit count of 
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aBstract: We describe a case of a 38 year-old Sri Lankan female who was referred to the surgeon on call with a 
picture of acute abdomen. She presented with a three-day history of fever, headache, abdominal pain and diarrhoea; 
however, the physical examination was not consistent with acute abdomen. Her platelet count was 22 x109/L. A 
diagnosis of dengue haemorrhagic fever (DHF) was made and dengue serology was positive. Dengue epidemics have 
been associated with a variety of gastrointestinal symptoms and signs, including acute abdomen. Acute abdomen in 
patients with DHF makes the diagnosis and management challenging. 
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39.9 %; platelet count 22 x109/L; white blood cell 
count 11.5 x109/L with neutrophils of 2.4 x109/L 
and lymphocytes of 4.8 x109/L; mildly raised 
alanine transaminase (ALT) of 86 IU/I, and alkaline 
phosphatase of 184 IU/L. Urea and electrolytes, 
coagulation profile and amylase were normal. An 
abdominal ultrasonography showed free fluid in 
the abdomen with a slightly thickened gall bladder 
wall, but no evidence of gall bladder calculi. The 
patient was referred to the surgical team with an 
initial diagnosis of acute cholecystitis. She was kept 
nil by mouth and was started on intravenous fluids 
and ceftriaxone injections. On the second day of 
admission, the patient continued to have severe 
abdominal pain and a clinically detected guarding 
abdomen. An urgent computed tomography (CT) 
scan of the chest and abdomen with oral and 
intravenous contrast was done. It showed bilateral 
pleural effusion with right lower lobe collapse and 
segmental atelectasis, and abdominal and pelvic 
ascites, but the gall bladder was normal. In view 
of the CT findings, acute cholecystitis was ruled 
out and an alternative diagnosis was considered. 
Malaria screening was negative. The blood film 
revealed very mild leukocytosis with reactive 
lymphocytes and a mild neutrophil left shift; the 
platelets were markedly reduced and showed 
occasional large forms. The features of the blood 
film were compatible with a viral infection; in view 
of the recent travel history to a dengue endemic 
country, dengue haemorrhagic fever (DHF) was 
suspected. 
The patient was managed conservatively and 
made a remarkable improvement clinically with a 
gradual increase in the platelet count. She was sent 
home on the fifth day after her admission, symptom 
free and with a platelet count of 224x109/L. 
Dengue serology was done on admission and was 
immunoglobulin M (IgM) positive; it was repeated 
two months later and the result was equivocal. 
Polymerase chain reaction (PCR) for dengue 
virus was requested on admission, but it was not 
done due to technical reasons in the laboratory. 
It was, however, done with the repeated serology 
two months after the initial presentation and was 
negative. 
Discussion
Dengue virus infection is the most common cause 
of arboviral disease in the world. The estimated 
annual occurrence of dengue fever is 100 million 
cases of dengue fever with 250,000 cases of DHF, 
and a mortality rate of 25,000 per year.1 In the 
last 50 years, the incidence has increased 30-
fold with geographic expansion to new countries 
and, in the present decade, from urban to rural 
settings.3 Dengue is endemic in most tropical and 
subtropical parts of the world. Some 1.8 billion 
(more than 70%) of the populations at risk for 
dengue worldwide live in member states of the 
World Health Organization’s (WHO) South-East 
Asia and Western Pacific regions which bear nearly 
75% of the current global disease burden due to 
dengue.2 Dengue is transmitted by the mosquito 
vectors Aedes aegypti and Aedes albopictus. Dengue 
infection is caused by any of 4 different serotypes 
of the virus (DEN-1, DEN-2, DEN-3, and DEN-4). 
The incubation period is 4–7 days after an infective 
mosquito bite.4 The recent emergence of DHF in the 
Indian subcontinent has been well documented in 
Sri Lanka. The four dengue virus (DENV) serotypes 
have been co-circulating in Sri Lanka for >30 years. 
Over this period, a new genotype of DENV-1 has 
replaced the old genotype. Moreover, new clades of 
DENV-3 genotype III viruses have replaced older 
clades. The emergence of new clades of DENV-3 in 
1989 and 2000 coincided with abrupt increases in 
the number of reported dengue cases, implicating 
this serotype in severe epidemics. From 1980 to 
1997, most reported dengue cases were in children. 
Recent epidemics have been characterised by many 
cases in both adults and children. Changes in local 
transmission dynamics and genetic changes in 
DENV-3 are probably responsible for the increasing 
emergence of severe dengue epidemics in Sri 
Lanka.5 There is no published data on dengue fever 
from Oman apart from one case report.6
The clinical manifestations of dengue range 
from asymptomatic infection, self-limited dengue 
fever to DHF with shock syndrome. The risk 
of severe disease is much higher in sequential 
rather than primary dengue infection.7 The most 
common symptoms of dengue virus infection are 
fever, headache, retro-orbital pain, photophobia, 
backache, severe myalgia and arthralgias. 
Other signs and symptoms include generalised 
maculopapular rash, lymphadenopathy, positive 
tourniquet test, petechiae and other haemorrhagic 
manifestations. The WHO has set criteria for 
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diagnosing dengue (with or without warning signs) 
and severe dengue depending on clinical signs 
and symptoms and laboratory investigations. The 
criteria for diagnosing probable dengue fever are 
living in or travel to a dengue endemic area, fever 
and two of the following criteria: nausea, vomiting, 
rash, aches, a positive tourniquet test, leukopenia 
and any warning sign. The warning signs are 
abdominal pain or tenderness, persistent vomiting, 
clinical fluid accumulation, mucosal bleeding, 
lethargy, restlessness, liver enlargement of >2cm 
and increase in haematocrit concurrent with a rapid 
decrease in platelet count. The diagnosis of severe 
dengue was defined by the WHO as severe plasma 
leakage leading to dengue shock syndrome (DSS); 
fluid accumulation with respiratory distress; severe 
bleeding as evaluated by the clinician, and severe 
organ involvement (acute liver failure, acute renal 
failure, encephalopathy, cardiomyopathy), or other 
unusual manifestations.3
About one-third of patients develop one or 
more complications that include bleeding, seizures, 
acute renal failure, and DSS. There have been 
reports of other uncommon clinical complications 
such as acute hepatitis and hepatic failure,8 unusual 
neurologic manifestations,9 and acute myocarditis.10 
There also have been reports of cases resembling 
surgical emergencies like acute pancreatitis, acute 
acalculous cholecystitis,11 acute appendicitis12 and 
non-specific peritonitis.
A retrospective study of patients with DHF 
and acute abdomen in a dengue epidemic area in 
southern Taiwan found that, of 328 patients with 
DHF/DSS, 14 had acute abdomen. DHF/DSS was 
initially suspected in only 2 of these 14 patients. 
Presumptive diagnoses of acute cholecystitis (6 
acalculus and 4 calculus cholecystitis) were made 
in 10 patients, non-specific peritonitis in three 
patients, and acute appendicitis in one patient. 
Cholecystectomy, percutaneous transhepatic 
gall bladder drainage, and appendectomy were 
performed in three patients. In addition to acute 
abdomen, these patients had a variety of symptoms 
and signs such as fever, chills, myalgia, headache, 
rashes, and petechiae, which were similar to 
those found in patients with DHF without acute 
abdomen.4 However, the predominant acute 
abdomen in these patients was the overwhelming 
concern and distracted clinicians from the typical 
clinical manifestations of dengue illness that should 
have been noticed.13
The treatment of DHF is mainly supportive care. 
In 2005, Wills et al. investigated fluid treatment 
for Vietnamese children with DSS.14 With the use 
of simple clinical monitoring tools, these authors 
have shown that the administration of Ringer’s 
lactate leads to the same outcome among children 
with moderate shock as does the administration of 
colloids.14 Guidelines for intravenous fluid therapy 
of DHF have been developed by the WHO. For 
patients with shock, an initial bolus of 5% dextrose 
in normal saline or Ringer's lactate (10 to 20 mL per 
kg of body weight) infused rapidly is recommended, 
followed by continuous infusion (10 to 20 mL/
kg per hour) until vital signs and urine output 
normalise. The infusion rate can then be gradually 
reduced until it matches plasma fluid losses.3
The symptoms and signs of our patient were 
mostly similar to those that have been previously 
described for dengue fever. Also the presence of 
thrombocytopenia, mild derangement of liver 
enzymes, evidence of plasma leakage (pleural 
effusion, ascites, hypoalbuminemia and raised 
haematocrit) and positive IgM serology for dengue 
all supported the diagnosis of DHF. However, the 
whole clinical picture was masked by acute severe 
abdominal pain and tenderness. The diagnosis 
was not made until the patient was referred to 
the infectious diseases team. This case underlines 
the need for medical staff to be aware of travel 
and tropical medicine including geographical 
epidemiology.
Conclusion 
Acute abdomen is an uncommon presentation 
of DHF. It is important to take dengue fever into 
consideration when making a differential diagnosis 
on acute abdomen for patients returning from 
dengue endemic regions. It may help in preventing 
unnecessary surgical intervention in DHF patients. 
It is also important for medical personnel to be 
aware of the epidemiology of tropical diseases. 
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